Context Therapeutics Inc. (CNTX) Tops Q1 EPS by 9c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q1 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS says bull market has further to run
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04